JNJ-632 is primarily investigated for its potential therapeutic applications in the treatment of neurological disorders, particularly those involving cognitive impairment or neurodegenerative conditions. Its mechanism of action targets specific pathways in the brain, making it a promising candidate for addressing memory loss, learning deficits, and other cognitive dysfunctions. Research suggests it may also have applications in mood disorders, such as depression or anxiety, by modulating neurotransmitter systems. Additionally, JNJ-632 is being explored for its potential to slow disease progression in conditions like Alzheimer's or Parkinson's, offering hope for improved quality of life in patients. Its development underscores a focus on precision medicine in neurology.